{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:16:18Z","timestamp":1789028178193,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Ministry of Health, Labour and Welfare of Japan","award":["20141508A, 25-2-3"],"award-info":[{"award-number":["20141508A, 25-2-3"]}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K09486"],"award-info":[{"award-number":["16K09486"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K07907"],"award-info":[{"award-number":["20K07907"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K07895"],"award-info":[{"award-number":["18K07895"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["21ek0109486, 21ek0109549, 21ek0109493"],"award-info":[{"award-number":["21ek0109486, 21ek0109549, 21ek0109493"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hereditary hemorrhagic telangiectasia (HHT) is a dominantly inherited vascular disorder characterized by recurrent epistaxis, skin\/mucocutaneous telangiectasia, and organ\/visceral arteriovenous malformations (AVM). HHT is mostly caused by mutations either in the <jats:italic>ENG<\/jats:italic> or <jats:italic>ACVRL1<\/jats:italic> genes, and there are regional differences in the breakdown of causative genes. The clinical presentation is also variable between populations suggesting the influence of environmental or genetic backgrounds. In this study, we report the largest series of mutational and clinical analyses for East Asians.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Using DNAs derived from peripheral blood leukocytes of 281 Japanese HHT patients from 150 families, all exons and exon\u2013intron boundaries of the <jats:italic>ENG<\/jats:italic>, <jats:italic>ACVRL1<\/jats:italic>, and <jats:italic>SMAD4<\/jats:italic> genes were sequenced either by Sanger sequencing or by the next-generation sequencing. Deletions\/amplifications were analyzed by the multiplex ligation-dependent probe amplification analyses. Clinical information was obtained by chart review.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 80 and 59 pathogenic\/likely pathogenic variants were identified in the <jats:italic>ENG<\/jats:italic> and <jats:italic>ACVRL1<\/jats:italic> genes, respectively. No pathogenic variants were identified in the <jats:italic>SMAD4<\/jats:italic> gene. In the <jats:italic>ENG<\/jats:italic> gene, the majority (60\/80) of the pathogenic variants were private mutations unique to a single family, and the variants were widely distributed without any distinct hot spots. In the <jats:italic>ACVRL1<\/jats:italic> gene, the variants were more commonly found in exons 5\u201310 which encompasses the serine\/threonine kinase domain. Of these, 25\/59 variants were unique to a single family while those in exons 8\u201310 tended to be shared by multiple (2\u20137) families. Pulmonary and cerebral AVMs were more commonly found in <jats:italic>ENG<\/jats:italic>-HHT (69.1 vs. 14.4%, 34.0 vs. 5.2%) while hepatic AVM was more common in <jats:italic>ACVRL1<\/jats:italic>-HHT (31.5 vs. 73.2%). Notable differences include an increased incidence of cerebral (34.0% in <jats:italic>ENG<\/jats:italic>-HHT and 5.2% in <jats:italic>ACVRL1<\/jats:italic>-HHT), spinal (2.5% in <jats:italic>ENG<\/jats:italic>-HHT and 1.0% in ACVL1-HHT), and gastric AVM (13.0% in <jats:italic>ENG<\/jats:italic>-HHT, 26.8% in <jats:italic>ACVRL1<\/jats:italic>-HHT) in our cohort. Intrafamilial phenotypic heterogeneity not related to the age of examination was observed in 71.4% and 24.1% of <jats:italic>ENG<\/jats:italic>- and <jats:italic>ACVRL1<\/jats:italic>-HHT, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In a large Japanese cohort, <jats:italic>ENG<\/jats:italic>-HHT was 1.35 times more common than <jats:italic>ACVRL1<\/jats:italic>-HHT. The phenotypic presentations were similar to the previous reports although the cerebral, spinal, and gastric AVMs were more common.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-021-01139-y","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T08:02:49Z","timestamp":1638777769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Mutational and clinical spectrum of Japanese patients with hereditary hemorrhagic telangiectasia"],"prefix":"10.1186","volume":"14","author":[{"given":"Kana","family":"Kitayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Komiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Morisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Morisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaku","family":"Minase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Hamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Miyatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomichi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Yorifuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,6]]},"reference":[{"key":"1139_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.otc.2017.09.017","volume":"51","author":"T K\u00fchnel","year":"2018","unstructured":"K\u00fchnel T. Hereditary hemorrhagic telangiectasia. Otolaryngol Clin North Am. 2018;51:237\u201354.","journal-title":"Otolaryngol Clin North Am"},{"key":"1139_CR2","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3324\/haematol.2018.193003","volume":"103","author":"A Kritharis","year":"2018","unstructured":"Kritharis A. Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist\u2019s perspective. Haematologica. 2018;103:1433\u201343.","journal-title":"Haematologica"},{"key":"1139_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/jmg.2005.030833","volume":"43","author":"SA Abdalla","year":"2006","unstructured":"Abdalla SA, Letarte M, et al. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet. 2006;43:97\u2013110.","journal-title":"J Med Genet"},{"key":"1139_CR4","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.3390\/jcm9113581","volume":"9","author":"EM de Gussem","year":"2020","unstructured":"de Gussem EM, Kroon S, Hosman AE, Kelder JC, Post MC, Snijder RJ, et al. Hereditary Hemorrhagic Telangiectasia (HHT) and Survival: the importance of systematic screening and treatment in HHT centers of excellence. J Clin Med. 2020;9:3581.","journal-title":"J Clin Med"},{"key":"1139_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","volume":"91","author":"CL Shovlin","year":"2000","unstructured":"Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu\u2013Osler\u2013Weber syndrome). Am J Med Genet. 2000;91:66\u20137.","journal-title":"Am J Med Genet"},{"key":"1139_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2350-10-53","volume":"10","author":"H Sadick","year":"2009","unstructured":"Sadick H, Hage J, Goessler U, Stern-Straeter J, Riedel F, Hoermann K, et al. Mutation analysis of \u201cEndoglin\u201d and \u201cActivin receptor-like kinase\u201d genes in German patients with hereditary hemorrhagic telangiectasia and the value of rapid genotyping using an allele-specific PCR-technique. BMC Med Genet. 2009;10:53.","journal-title":"BMC Med Genet"},{"key":"1139_CR7","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.celrep.2017.05.011","volume":"19","author":"T Saito","year":"2017","unstructured":"Saito T, Bokhove M, Croci R, Zamora-Caballero S, Han L, Letarte M, et al. Structural basis of the human endoglin-BMP9 interaction: insights into BMP signaling and HHT1. Cell Rep. 2017;19:1917\u201328.","journal-title":"Cell Rep"},{"key":"1139_CR8","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.3390\/jcm9113571","volume":"9","author":"C Bernabeu","year":"2020","unstructured":"Bernabeu C, Bayrak-Toydemir P, McDonald J, Letarte M, et al. Potential second-hits in hereditary hemorrhagic telangiectasia. J Clin Med. 2020;9:3571.","journal-title":"J Clin Med"},{"key":"1139_CR9","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S0140-6736(04)15732-2","volume":"363","author":"CJ Gallione","year":"2004","unstructured":"Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet. 2004;363:852\u20139.","journal-title":"Lancet."},{"key":"1139_CR10","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/jmg.2004.028712","volume":"42","author":"SG Cole","year":"2005","unstructured":"Cole SG, Begbie ME, Wallace GM, Shovlin CL, et al. A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet. 2005;42:577\u201382.","journal-title":"J Med Genet"},{"key":"1139_CR11","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1002\/ajmg.a.31450","volume":"140","author":"P Bayrak-Toydemir","year":"2006","unstructured":"Bayrak-Toydemir P, McDonald J, Akarsu N, Toydemir RM, Calderon F, Tuncali T, et al. A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet A. 2006;140:2155\u201362.","journal-title":"Am J Med Genet A"},{"key":"1139_CR12","unstructured":"University of Utah ARUP Scientific Resource for Research and Education: ENG Database. http:\/\/arup.utah.edu\/database\/ENG\/ENG_display.php. Accessed 27 Aug 2021."},{"key":"1139_CR13","unstructured":"University of Utah ARUP Scientific Resource for Research and Education: ACVRL1 Database. http:\/\/arup.utah.edu\/database\/ACVRL1\/ACVRL1_display.php. Accessed 27 Aug 2021."},{"key":"1139_CR14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s13023-020-01533-2","volume":"15","author":"S Giraud","year":"2020","unstructured":"Giraud S, Bardel C, Dupuis-Girod S, Carette MF, Gilbert-Dussardier B, Riviere S, et al. Sequence variations of ACVRL1 play a critical role in hepatic vascular malformations in hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis. 2020;15:254.","journal-title":"Orphanet J Rare Dis"},{"key":"1139_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/cge.12269","volume":"86","author":"PM T\u00f8rring","year":"2014","unstructured":"T\u00f8rring PM, Brusgaard K, Ousager LB, Andersen PE, Kjeldsen AD, et al. National mutation study among Danish patients with hereditary haemorrhagic telangiectasia. Clin Genet. 2014;86:123\u201333.","journal-title":"Clin Genet"},{"key":"1139_CR16","doi-asserted-by":"crossref","unstructured":"Letteboer TG, Mager JJ, Snijder RJ, Koeleman BP, Lindhout D, Ploos van Amstel JK, et al. Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet. 2006;43:371\u20137.","DOI":"10.1136\/jmg.2005.035451"},{"key":"1139_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.5469\/neuroint.2019.00150","volume":"14","author":"D Kim","year":"2019","unstructured":"Kim D, Seo E-J, Song YS, Suh CH, Kim JW, Kim DJ, Suh DC, et al. Current status of clinical diagnosis and genetic analysis of hereditary hemorrhagic telangiectasia in South Korea: multicenter case series and a systematic review. Neurointervention. 2019;14:91\u20138.","journal-title":"Neurointervention"},{"key":"1139_CR18","doi-asserted-by":"crossref","unstructured":"Zhao Y, Zhang Y, Wang X, Zhang L, et al. Variant analysis in Chinese families with hereditary hemorrhagic telangiectasia. Mol Genet Genomic Med. 2019;7:e893.","DOI":"10.1002\/mgg3.893"},{"key":"1139_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/jhg.2013.113","volume":"59","author":"M Komiyama","year":"2014","unstructured":"Komiyama M, Ishiguro T, Yamada O, Morisaki H, Morisaki T, et al. Hereditary hemorrhagic telangiectasia in Japanese patients. J Hum Genet. 2014;59:37\u201341.","journal-title":"J Hum Genet"},{"key":"1139_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jpeds.2018.01.079","volume":"197","author":"KS Pahl","year":"2018","unstructured":"Pahl KS, Choudhury A, Wusik K, Hammill A, White A, Henderson K, et al. Applicability of the cura\u00e7ao criteria for the diagnosis of hereditary hemorrhagic telangiectasia in the pediatric population. J Pediatr. 2018;197:207\u201313.","journal-title":"J Pediatr"},{"key":"1139_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Guideline Genet Med. 2015;17:405\u201324.","journal-title":"Guideline Genet Med"},{"key":"1139_CR22","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/j.1538-7836.2007.02531.x","volume":"5","author":"C Sabb\u00e0","year":"2007","unstructured":"Sabb\u00e0 C, Pasculli G, Lenato GM, Suppressa P, Lastella P, Memeo M, et al. Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost. 2007;5:1149\u201357.","journal-title":"J Thromb Haemost"},{"key":"1139_CR23","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/MCP.0000000000000472","volume":"24","author":"S Kroon","year":"2018","unstructured":"Kroon S, Snijder RJ, Faughnan ME, Mager HJ, et al. Systematic screening in hereditary hemorrhagic telangiectasia: a review. Curr Opin Pulm Med. 2018;24:260\u20138.","journal-title":"Curr Opin Pulm Med"},{"key":"1139_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/gim.2013.62","volume":"16","author":"C Canzonieri","year":"2014","unstructured":"Canzonieri C, Centenara L, Ornati F, Pagella F, Matti E, Alvisi C, et al. Endoscopic evaluation of gastrointestinal tract in patients with hereditary hemorrhagic telangiectasia and correlation with their genotypes. Genet Med. 2014;16:3\u201310.","journal-title":"Genet Med"},{"key":"1139_CR25","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1007\/s10620-017-4719-3","volume":"62","author":"SB Jackson","year":"2017","unstructured":"Jackson SB, Villano NP, Benhammou JN, Lewis M, Pisegna JR, Padua D, et al. Gastrointestinal manifestations of hereditary hemorrhagic telangiectasia (HHT): a systematic review of the literature. Dig Dis Sci. 2017;62:2623\u201330.","journal-title":"Dig Dis Sci"},{"key":"1139_CR26","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.gie.2009.11.004","volume":"71","author":"E Gr\u00e8ve","year":"2010","unstructured":"Gr\u00e8ve E, Moussata D, Gaudin JL, Lapalus MG, Giraud S, Dupuis-Girod S, et al. High diagnostic and clinical impact of small-bowel capsule endoscopy in patients with hereditary hemorrhagic telangiectasia with overt digestive bleeding and\/or severe anemia. Gastrointest Endosc. 2010;71:760\u20137.","journal-title":"Gastrointest Endosc"},{"key":"1139_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13023-020-01453-1","volume":"15","author":"JD Beckman","year":"2020","unstructured":"Beckman JD, Li Q, Hester ST, Leitner O, Smith KL, Kasthuri RS, et al. Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding. Orphanet J Rare Dis. 2020;15:185.","journal-title":"Orphanet J Rare Dis"},{"key":"1139_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/GIM.0b013e31802d8373","volume":"9","author":"G Lesca","year":"2007","unstructured":"Lesca G, Olivieri C, Burnichon N, Pagella F, Carette MF, Gilbert-Dussardier B, et al. Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network. Genet Med. 2007;9:14\u201322.","journal-title":"Genet Med"},{"key":"1139_CR29","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/humu.9345","volume":"25","author":"C Schulte","year":"2005","unstructured":"Schulte C, Geisthoff U, Lux A, Kupkal S, Zenner HP, Blin N, et al. High frequency of ENG and ALK1\/ACVRL1 mutations in German HHT patients. Hum Mutat. 2005;25:595.","journal-title":"Hum Mutat"},{"key":"1139_CR30","doi-asserted-by":"crossref","unstructured":"Major T, Gindele R, Balogh G, B\u00e1rdossy P, Bereczky Z. et al. Founder effects in hereditary hemorrhagic telangiectasia. J Clin Med. 2021;10:1682.","DOI":"10.3390\/jcm10081682"},{"key":"1139_CR31","doi-asserted-by":"publisher","first-page":"9967","DOI":"10.1007\/s11033-020-05985-4","volume":"47","author":"TT Mutize","year":"2020","unstructured":"Mutize TT, Seedat RY, van Amstel JKP, Mager JJ, Brown SC, Gebremariam F, et al. The clinical and genetic features of hereditary haemorrhagic telangiectasia (HHT) in central South Africa-three novel pathogenic variants. Mol Biol Rep. 2020;47:9967\u201372.","journal-title":"Mol Biol Rep"},{"key":"1139_CR32","first-page":"32","volume":"2","author":"GN Goulielmos","year":"2016","unstructured":"Goulielmos GN, Eliopoulos E, Karatzanis A, Zervou MI, Fountakis E, et al. Mutational analysis mapping on the molecular structure of the ACVRL1 protein and implications for Rendu\u2013Osler\u2013Weber (ROW). Int J New Innov Eng Technol. 2016;2:32\u20136.","journal-title":"Int J New Innov Eng Technol"},{"key":"1139_CR33","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3171\/2017.3.PEDS16587","volume":"20","author":"A Rattani","year":"2017","unstructured":"Rattani A, Dewan MC, Hannig V, Naftel RP, Wellons JC 3rd, Jordan LC, et al. Cerebral hemorrhage in monozygotic twins with hereditary hemorrhagic telangiectasia: case report and hemorrhagic risk evaluation. J Neurosurg Pediatr. 2017;20:164\u20139.","journal-title":"J Neurosurg Pediatr"},{"key":"1139_CR34","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/0002-9343(86)90372-4","volume":"81","author":"BA Lesser","year":"1986","unstructured":"Lesser BA, Wendt D, Miks VM, Norum RA, et al. Identical twins with hereditary hemorrhagic telangiectasia concordant for cerebrovascular arteriovenous malformations. Am J Med. 1986;81:931\u20134.","journal-title":"Am J Med"},{"key":"1139_CR35","first-page":"614","volume":"22","author":"M Komiyama","year":"2019","unstructured":"Komiyama M, Ishiguro T, Tereda A. Monozygotic twins with endoglin mutations. Angiogenesis. 2019;22:614.","journal-title":"Angiogenesis"},{"key":"1139_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10072-014-1917-z","volume":"36","author":"K Suzuki","year":"2015","unstructured":"Suzuki K, Izumi M. The incidence of hemorrhagic stroke in Japan is twice compared with western countries: the Akita stroke registry. Neurol Sci. 2015;36:155\u201360.","journal-title":"Neurol Sci"},{"key":"1139_CR37","doi-asserted-by":"crossref","unstructured":"Wong MCS, Huang J, Chan PSF, Choi P, Lao XQ, Chan SM, et al. Global incidence and mortality of gastric cancer, 1980\u20132018. JAMA Netw Open. 2021;4:e2118457.","DOI":"10.1001\/jamanetworkopen.2021.18457"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-021-01139-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-021-01139-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-021-01139-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T20:04:06Z","timestamp":1638821046000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-021-01139-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1139"],"URL":"https:\/\/doi.org\/10.1186\/s12920-021-01139-y","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"11 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board at Osaka City General Hospital (No. 170850) and the study was performed under written informed consent from the patients or the guardians when appropriate. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"288"}}